Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Advanced Prostate Cancer × Goserelin × Clear all

Phase

Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 39 Breast Neoplasms 28 Breast Neoplasms, Male 3 Neoplasm Metastasis 2 Infertility 2 Advanced Breast Cancer 2 Sexual Dysfunction, Physiological 1 Recurrence 1 Primary Ovarian Insufficiency 1 Osteoporosis 1 Osteitis Deformans 1 Neoplasms 1 Leiomyoma 1 Hot Flashes 1 Hemorrhage 1 Breast Cancer Invasive 1 Anemia 1 Advanced Prostate Cancer 1 Advanced Metastatic Breast Cancer 1

Interventions

Leuprolide 1 Goserelin 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03936218 2025-04-17

Goserelin 10.8mg Injection in Treatment of Advanced Prostate Cancer

Eurofarma Laboratorios S.A.

Phase 3 Completed

Advanced Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡